Ausdal Financial Partners, Inc. Bausch Health Companies Inc. Transaction History

Ausdal Financial Partners, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$7.69 - $9.71 $80,745 - $101,955	10,500 New	10,500 $86,000
Q3 2021 Nov 01, 2021	SELL	$25.04 - $30.06 $211,588 - $254,007	-8,450 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$21.37 - $34.38 $180,576 - $290,511	8,450 New	8,450 $268,000
Q1 2020 May 04, 2020	SELL	$12.98 - $30.25 $94,754 - $220,825	-7,300 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $56,670 - $95,670	-3,000 Reduced 29.13%	7,300 $213,000
Q3 2019 Nov 19, 2019	BUY	$20.88 - $25.66 $6,264 - $7,698	300 Added 3.0%	10,300 $225,000
Q2 2019 Aug 05, 2019	SELL	$20.52 - $26.45 $37,551 - $48,403	-1,830 Reduced 15.47%	10,000 $247,000
Q1 2019 May 13, 2019	BUY	$20.23 - $26.29 $25,793 - $33,519	1,275 Added 12.08%	11,830 $292,000
Q4 2018 Feb 11, 2019	SELL	$17.64 - $28.32 $181,145 - $290,818	-10,269 Reduced 49.31%	10,555 $195,000
Q3 2018 Nov 09, 2018	BUY	$20.64 - $25.67 $429,807 - $534,552	20,824 New	20,824 $535,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Ausdal Financial Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ausdal Financial Partners, Inc. with notifications on news.